SCOPUS 정보 검색 플랫폼

Volumn 22, Issue 9, 2009, Pages 950-

Using plasma renin (PRA) testing to design follow-up drug treatment strategies in hypertensive patients already taking antirenin system drugs

(2) Sealey, Jean E a Laragh, John H b

a WEILL CORNELL MEDICAL COLLEGE (United States)

b NEW YORK PRESBYTERIAN HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NATRIURETIC FACTOR; RENIN INHIBITOR;

BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HYPERTENSION; NOTE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

AMIDES; ANTIHYPERTENSIVE AGENTS; FUMARATES; HUMANS; HYPERTENSION; RENIN;

EID: 69249131743 PISSN: 08957061 EISSN: None Source Type: Journal
DOI: 10.1038/ajh.2009.123 Document Type: Note

Times cited : (5)

References (5)

1
- 69249202278
- Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively
- Stanton AV, Dicker P, O'Brien ET. Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively. Am J Hypertens 2009; 22:954-957.
- (2009) Am J Hypertens , vol.22 , pp. 954-957
- Stanton, A.V.¹ Dicker, P.² O'Brien, E.T.³

2
- 57749203164
- Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises
- Sealey JE, Laragh JH. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises. Am J Hypertens 2009; 22:112-121.
- (2009) Am J Hypertens , vol.22 , pp. 112-121
- Sealey, J.E.¹ Laragh, J.H.²

3
- 0034993731
- Laragh's lessons in pathophysiology and clinical pearls for treating hypertension: Lesson XVI: how to choose the correct drug treatment for each hypertensive patient using a plasma renin-based method with volume-vasoconstriction analysis
- Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension: lesson XVI: how to choose the correct drug treatment for each hypertensive patient using a plasma renin-based method with volume-vasoconstriction analysis. Am J Hypertens 2001; 14:491-503.
- (2001) Am J Hypertens , vol.14 , pp. 491-503
- Laragh, J.¹

4
- 34247644329
- Aliskiren, the first renin inhibitor for treating hypertension: Reactive renin secretion may limit its effectiveness
- Sealey JE, Laragh JH. Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. Am J Hypertens 2007; 20:587-597.
- (2007) Am J Hypertens , vol.20 , pp. 587-597
- Sealey, J.E.¹ Laragh, J.H.²

5
- 67649361948
- Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: A randomized controlled trial
- Egan B, Basile J, Rehman S, Davis P, Grob C, Riehle J, Walters CA, Lackland DT, Merali C, Sealey JE, Laragh JH. Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens 2009; 22:792-801.
- (2009) Am J Hypertens , vol.22 , pp. 792-801
- Egan, B.¹ Basile, J.² Rehman, S.³ Davis, P.⁴ Grob, C.⁵ Riehle, J.⁶ Walters, C.A.⁷ Lackland, D.T.⁸ Merali, C.⁹ Sealey, J.E.¹⁰ Laragh, J.H.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.